Rpi US Partners 2019, LP
Private Equity FundFund ID 805-1073047392Delaware, United States
Gross assets
$1.44B
Min. investment
—
Beneficial owners
60
Size rank
Top 5%
Audited
Yes
Structure
Standalone
About this fund
Rpi US Partners 2019, LP is a private equity fund managed by Royalty Pharma Sub-Manager, LLC. The fund reports $1.4 billion in gross assets, placing it among the top 5% of private funds by size. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.
Fund details
| Fund ID | 805-1073047392 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
Other funds from this manager
| Fund | Type | Gross assets |
|---|---|---|
| Rpi International Partners 2019, LP | Private Equity | $6.8M |
Frequently asked questions
How large is Rpi US Partners 2019, LP?
Rpi US Partners 2019, LP reports $1.4 billion in gross assets, among the top 5% of private funds by size.
Who manages Rpi US Partners 2019, LP?
Rpi US Partners 2019, LP is managed by Royalty Pharma Sub-Manager, LLC.
Does Rpi US Partners 2019, LP disclose returns?
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.
Manager
R
New York, NY
Service providers
Reported gross assets
$1.44B▼ 14%
Mar '25Form ADV, monthlyJun '26
How this fund compares
Gross assetsTop 5%
Larger than 95% of 67,041 private funds
Gross assets vs Private Equity FundsTop 4%
Larger than 96% of 31,066 private equity funds
Investor base
Adviser & related persons78%
Funds of funds%
Non-U.S. persons%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.